Integra Lifesciences (NASDAQ: IART) revenue
Integra Lifesciences reported revenue of $1,635m for fiscal 2025, 1.5% more than in fiscal 2024 ($1,611m). Since fiscal 2016 its revenue has grown by 64.8%, an average growth of 5.7% a year.
Integra Lifesciences has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −9.6%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $1,635m | +1.5% | −$493.4m | −30.2% |
| 2024 | $1,611m | +4.5% | $28.4m | 1.8% |
| 2023 | $1,542m | −1.0% | $111.5m | 7.2% |
| 2022 | $1,558m | +1.0% | $238.9m | 15.3% |
| 2021 | $1,542m | +12.4% | $197.2m | 12.8% |
| 2020 | $1,372m | −9.6% | $151.4m | 11.0% |
| 2019 | $1,518m | +3.1% | $93.8m | 6.2% |
| 2018 | $1,472m | +23.9% | $111.0m | 7.5% |
| 2017 | $1,188m | +19.8% | $44.8m | 3.8% |
| 2016 | $992.1m | — | $115.3m | 11.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Integra Lifesciences revenue compared with its sector
By revenue for its latest fiscal year, Integra Lifesciences ranks 122nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Integra Lifesciences, 1.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 120th | Healthcare Services Group | $1,837m | 7.1% |
| 121st | PTC Therapeutics | $1,731m | 114.5% |
| 122nd | Integra Lifesciences | $1,635m | 1.5% |
| 123rd | Lantheus | $1,542m | 0.5% |
| 124th | Phibro Animal Health | $1,518m | 17.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Integra Lifesciences
- How much revenue did Integra Lifesciences make in fiscal 2025?
- Integra Lifesciences reported revenue of $1,635m for fiscal 2025, compared with $1,611m in fiscal 2024.
- How much has the revenue of Integra Lifesciences grown?
- Between fiscal 2016 and fiscal 2025 it went from $992.1m to $1,635m: 64.8% more, an average growth of 5.7% a year.
- What was the best year for revenue at Integra Lifesciences?
- Of its last 10 fiscal years, fiscal 2025, with $1,635m.
- Where does Integra Lifesciences rank in its sector by revenue?
- It ranks 122nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Integra Lifesciences come from?
- From the annual report (Form 10-K) that Integra Lifesciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Integra Lifesciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Integra Lifesciences: the Integra Lifesciences page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.